This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...

About Relmada Therapeutics, Inc. Relmada is a clinical-stage biotechnology company focused on developing transformative therapies for oncology-related and central nervous system conditions. Its lead ...

The LGL Group, Inc. (NYSE American: LGL) (NYSE American: LGL WS) (“LGL Group” or the “Company”) today announced that its Board of Directors ...

Warrants to purchase 60,000 shares of common stock will be exercised at their existing exercise price of $2.00 per share, warrants to purchase 948,596 shares of common stock will be exercised at their ...

MultiSensor AI Holdings, Inc. (NASDAQ: MSAI) ("MSAI," "we," "our" or the "Company"), a pioneer in AI-powered industrial ...

CompoSecure ( ($CMPO) ) has issued an announcement. On November 3, 2025, CompoSecure, Inc. announced the redemption of all its outstanding public ...

Investing.com -- Rubico Inc. (NASDAQ:RUBI) stock tumbled 51.4% Wednesday after the shipping transportation services provider announced the pricing of a highly dilutive public offering.

Not for distribution to United States newswire services or for dissemination in the United States VANCOUVER, BC / ACCESS Newswire / November 6, ...

Benitec Biopharma Inc. (Nasdaq: BNTC) ('Benitec” or the 'Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA- ...

The program, which commenced in late August and concluded on October 27, comprised 10 diamond drill holes totaling 4,561 ...

Lion Copper and Gold Corp. (CSE: LEO) (OTCQB: LCGMF) (“Lion CG”, or the “Company”) is pleased to announce that it has closed ...

Successful completion of first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval -- -- $12 million senior secured converti ...